Clinical Trials Sponsored by Liangjun Zhu M.M.

Total 12 results

Liangjun Zhu M.M.
Zhangjiagang First People's Hospital

Recruiting

Envafolimab Combined With Chemotherapy in Metastatic or Recurrent Gastric Adenocarcinoma

Metastatic or Recurrent Gastric Adenocarcinoma

China
Zhu Mingjun

Unknown

A Clinical Research of Qi Deficiency and Blood Stasis Syndrome (Different Disease With Syndrome)

Ischemic Heart Failure

China
Zhi-Hong Liu, M.D.

Terminated

The Clinical Efficacy of DFPP in Patients With AAGN

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

China
Zhi-Hong Liu, M.D.

Completed

An Multi-site Prospective Study to Assess the Efficacy and Safety of MMF in the Treatment of Proliferative IgA Nephropathy(IgAN)

IgA Nephropathy (IgAN)

China
Zhi-Hong Liu, M.D.

Completed

Bortezomib for Immunoglobulin Light Chain(AL) Amyloidosis

Amyloidosis
Zhi-Hong Liu, M.D.

Terminated

Randomized Clinical Trial of Triptolide Woldifii for Autosomal Dominant Polycystic Kidney Disease

Polycystic Kidney

China
Jian-cang Zhou M.D.

Completed

Community-Onset Bacteremia Due to ESBL Producing E.Coli or K.Pneumoniae in China: Prevalence, Risk Factors and Prognosis

Community Acquired Infection

China
Zhi-Hong Liu, M.D.

Terminated

A Prospective, Single-center, Randomized, Controlled Study of Sevelamer Carbonate in the Lipid Metabolism and Uric Acid Treatment of Obesity-Related Glomerulopathy

Obesity and Glomerulopathy

China
Zhi-Hong Liu, M.D.

Completed

Long-Term Study of Multi-target Therapy as Maintenance Treatment for Lupus Nephritis

Lupus Nephritis

China
Zhi-Hong Liu, M.D.

Completed

Treatment of Idiopathic Membranous Nephropathy With Tripterygium Wilfordii Plus Steroid vs Tacrolimus Plus Steroid

Idiopathic Membranous Nephropathy

China
Zhi-Hong Liu, M.D.
Nanjing Medical University; Soochow University

Completed

Study of Bortezomib +HSCT in Primary Systemic Amyloidosis (AL)

Amyloidosis

China
Zhi-Hong Liu, M.D.
The First Affiliated Hospital with Nanjing Medical University; China Medical... and other collaborators

Completed

Assess the Efficacy and Safety of Multi-target Therapy in Lupus Nephritis

Lupus Nephritis

China

3

Subscribe